ABSTRACT A porcine parainfluenza virus type 1 (species Porcine respirovirus 1) cell culture isolate, USA/MN25890NS/2016, was obtained from porcine nasal swabs, and its complete genome sequence (GenBank accession number MF681710) was determined to help further characterize this virus.
P
orcine parainfluenza virus type 1 (PPIV-1) (species Porcine respirovirus 1) was first identified in 2013 from nasopharyngeal samples collected from deceased slaughterhouse pigs in Hong Kong, China. The PPIV-1 genome was reported at that time to be a novel paramyxovirus with highest genetic similarity to Sendai virus and human parainfluenza virus type 1 (1).
Porcine respirovirus type 1 is a member of the genus Respirovirus in the Paramyxoviridae family and is an enveloped, single-stranded, negative sense RNA virus (1) . PPIV-1 is widespread in the United States and has been detected by real-time reverse transcription PCR (rRT-PCR) in all ages of swine but more commonly in nursery and grow-finish pigs. PPIV-1 has been detected in respiratory samples, including lung tissues, nasal swabs, and oral fluids that have been submitted to the Iowa State University Veterinary Diagnostic Laboratory (2) . Viral infection has been associated with respiratory disease in pigs with clinical signs that may include coughing, minor sneezing, and serous nasal discharge (3). It has been suggested that PPIV-1 may play a role in the porcine respiratory disease complex (2) . However, the pathogenesis of PPIV-1 has not been fully elucidated, and the causal links between PPIV-1 and disease have not been established. Obtaining a PPIV-1 isolate propagated in cell culture is critical for experimental challenge to evaluate the pathogenesis and clinical significance of viral infection in swine. In addition, the availability of a PPIV-1 isolate can help develop and validate virological and serological diagnostic assays and assist vaccine development.
Virus isolation was attempted using rRT-PCR-positive respiratory samples from random submissions with a history of respiratory disease. The virus was eventually isolated from nasal swabs and confirmed by observing a cytopathic effect in tissue culture, rRT-PCR analysis, and Sanger sequencing of the hemagglutinin-neuraminidase (HN) and fusion (F) genes.
The complete genome of PPIV-1 isolate USA/MN25890NS/2016 was acquired using next-generation sequencing (NGS) technology on an Illumina MiSeq platform and analyzed using the DNASTAR Lasergene 12 following previously described procedures (4, 5) . The sequence consists of 15,334 nucleotides and encodes six open reading frames (3=-N-P-M-F-HN-L-5=). The HN and F genes are major glycoproteins on the viral surface suspected to play an important role in receptor binding, fusion, and penetration (6).
The full genome sequence of this PPIV-1 isolate is more closely related to PPIV-1 strains detected in the United States in 2016 (GenBank accession numbers KT749882 and KT749883), forming a clade with 98.1% and 98.2% nucleotide homology in a phylogenetic analysis using Clustal W in DNASTAR Lasergene 12. In contrast, the PPIV-1 whole genome demonstrated 91.3%, 95.9%, and 96% identities with virus strains detected in Hong Kong in 2013 (accession numbers JX857410, JX857409, and JX857411, respectively). These data suggest that the PPIV-1 virus is genetically evolving over time and at different geographic locations.
The association of this PPIV-1 sequence with clinical respiratory disease in swine remains unknown. Further analysis and experimental challenge are required to determine the clinical significance of this PPIV-1 isolate. Accession number(s). The complete genome sequence of PPIV-1 isolate USA/ MN25890NS/2016 has been deposited in GenBank under the accession number MF681710.
